Skip to main content

Table 3 Univariate and multivariate analysis of postoperative overall complications

From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Variables No complications Complications Univariate analysis Multivariate analysis
135 145 P OR (95% CI) P
Gender (male/female) 116/19 122/23 0.675   
Age (year) (≤ 50 vs > 50) 69/66 62/83 0.027   
Diabetes (yes vs no) 9/126 13/132 0.475   
Hypertension (yes vs no) 24/111 29/116 0.635   
ASA grading (≤ 2 vs > 2) 101/34 94/51 0.069   
Total bilirubin (μmol/L) 15.2 ± 8.0 33.0 ± 61.9 0.001   
Albumin (g/L) 40.7 ± 5.1 37.7 ± 5.5 < 0.001 0.922 (0.871–0.975) 0.004
ALT (U/L) 38.0 ± 23.0 69.4 ± 73.3 <0.001 1.012 (1.001–1.022) 0.026
AST (U/L) 37.7 ± 19.7 74.4 ± 81.9 < 0.001   
GP73 (≤ 80.9 vs > 80.9 ng/mL) 108/27 53/92 < 0.001 3.996 (2.152–7.421) < 0.001
Size of tumor (cm) 6.1 ± 3.4 6.3 ± 3.8 0.749   
Number of tumors 1.1 ± 0.4 1.2 ± 0.5 0.521   
Operation time (min) 200.9 ± 65.4 263.9 ± 267.9 0.008   
Blood loss (mL) 546.1 ± 510.5 1051.0 ± 1197.5 < 0.001   
Intraoperative RBC transfusion 1.9 ± 2.0 3.8 ± 4.3 < 0.001 1.206 (1.069–1.359) 0.002
  1. AST aspartate aminotransferase, ALT alanine aminotransferase, ASA American Society of Anesthesiology, RBC red blood cell